Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Upslope Capital Opens Short Position In Crown Holdings, Inc. (CCK)

Upslope Capital recently published its Q4 investor letter in which the investment firm discussed important changes to its portfolio positions during the quarter. Among the key changes is initiating a short position in Crown Holdings, Inc. (NYSE:CCK), a $7.4-billion consumer packaging company based in Philadelphia, Pennsylvania. Let’s take a look at Upslope Capital’s commentary on Crown Holdings.

George Livadas, the founder and portfolio manager of Upslope Capital, wasn’t happy with Crown Holdings’s bet to acquire Signode Industrial Group for $3.91 billion in cash. He writes in the letter:

Since inception of Upslope’s strategy (at a prior firm), Crown has been one of our largest long positions. However, a large acquisition in an unrelated business, announced just six days before Christmas ticked the ‘very questionable capital allocation’ box for me. Crown’s $4 bn acquisition of Signode – an industrial/transit packaging company – undercut a number of the reasons I (and I suspect other shareholders) liked the stock: predictable, a cyclical cash flows, de-leveraging, ramping share buybacks, and the prospect of a dividend. The deal, which added a materially cyclical business and a significant amount of debt, negated each of these attributes.

Why did Upslope Capital decide to open a short position in Crown Holdings, Inc. (NYSE:CCK)? Livadas says:

Most of the time, when I decide to exit a long position, flipping and initiating a short position is not actively considered. However, in my view, there are few more obvious ‘green-lights’ to short a stock than a questionable, seemingly empire-building acquisition. While it’s possible Signode will ultimately be a win for Crown, I believe the odds favor value destruction due to the flimsy strategic rationale. As one analyst asked during Crown’s call announcing the deal: “how does Crown become a better company…[with] Signode in the portfolio?” Management did not have a good answer.

Pixabay/Public Domain

Pixabay/Public Domain

Crown Holdings, Inc. (NYSE:CCK) is a supplier of packaging products to consumer marketing companies around the world. It makes metal beverage and food cans, metal aerosol containers, metal closures and specialty packing. The company claims to manufacture one out of every five beverage cans used in the world, and one out of every three food cans used in North America and Europe. Shares of the consumer packaging company are down nearly 5% since the beginning of the year. Whereas, the stock has moved up just 0.81% during the last 12 months. The stock value jumped 7% during the last year.

For the full-year 2017, Crown Holdings reported net sales of $8.7 billion, up compared to $8.3 billion in 2016. Net income attributable to the company was $323 million, down compared to $496 million in 2016. Earnings per share were $2.38 last year, compared to $3.56 in 2016, while adjusted earnings per share were $4.03 in 2017, versus $3.93 in 2016.

Meanwhile, there were 21 hedge funds in Insider Monkey’s database with positions in Crown Holdings at the end of September last year, including YG Partners, Osterweis Capital Management, and Adage Capital Management.

Disclosure: none

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.